| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT07610564 A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults… |
Recruitment opened |
| 2026-08-14 | NCT07610564 A Study to Assess the Effect of Empasiprubart on Nerve Morphology by Ultrasound in Adults… |
Trial sites expanded: 0 -> 3 locations |
| 2026-08-13 | NCT07570316 A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… |
Trial sites expanded: 18 -> 22 locations |
| 2026-08-11 | NCT06298552 A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With… |
date change Completion pushed: 2027-06 -> 2028-06 |
| 2026-08-11 | NCT07287982 A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and… |
Trial sites expanded: 17 -> 24 locations |
| 2026-07-31 | NCT07284420 ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to… |
Trial sites expanded: 15 -> 24 locations |
| 2026-07-31 | NCT07294170 ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy… |
Trial arms changed: 1 -> 2 |
| 2026-07-31 | NCT07294170 ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy… |
Trial sites expanded: 18 -> 29 locations |
| 2026-07-25 | NCT07673627 ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of… |
Recruitment opened |
| 2026-07-25 | NCT06436742 A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants… |
overall status: Recruiting → Active, Not Recruiting |
| 2026-07-25 | NCT05523167 A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult… |
Trial completed |
| 2026-07-25 | NCT05523167 A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult… |
Primary endpoint(s) modified |
| 2026-07-25 | NCT05523167 A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult… |
date change Primary completion moved earlier: 2026-12-01 -> 2026-07-02 |
| 2026-07-25 | NCT05523167 A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult… |
date change Completion moved earlier: 2027-02-01 -> 2026-07-02 |
| 2026-07-23 | NCT07091630 A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP |
Trial sites expanded: 61 -> 71 locations |
| 2026-07-22 | NCT06920004 A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP |
Trial sites expanded: 75 -> 82 locations |
| 2026-07-21 | NCT07583641 A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune… |
date change Primary completion moved earlier: 2030-12-04 -> 2029-01-20 |
| 2026-07-21 | NCT07583641 A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune… |
date change Completion moved earlier: 2031-07-26 -> 2029-05-12 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-12 | NCT07760818 A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's… | Phase 2 | Not Yet Recruiting |
| 2026-08-04 | NCT07746089 A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06909214 | A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With… | New Onset Generalized Myasthenia Gravis (gMG) | Recruiting |
| Phase 3 | |||
| NCT06544499 | A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With… | Primary Immune Thrombocytopenia (ITP) | Recruiting |
| NCT07596849 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… | Graves Disease | Recruiting |
| NCT06920004 | A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP | Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting |
| NCT07091630 | A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP | Chronic Inflammatory Demyelinating Polyneuropathy | Recruiting |
| NCT07570316 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants… | Graves' Disease | Recruiting |
| NCT04812925 | A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in… | Primary Immune Thrombocytopenia | Active, Not Recruiting |
| NCT06684847 | A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's… | Primary Sjogrens Disease | Active, Not Recruiting |
| NCT06742190 | A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With… | Multifocal Motor Neuropathy (MMN) | Active, Not Recruiting |
| NCT06558279 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular… | Myasthenia Gravis, Ocular | Active, Not Recruiting |
| NCT05979441 | A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of… | Myositis | Enrolling by Invitation |
| NCT07746089 | A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants… | Congenital Myasthenic Syndrome | Not Yet Recruiting |
| NCT06298552 | A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With… | Generalized Myasthenia Gravis | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT04833894 | Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod… | Generalized Myasthenia Gravis | Recruiting |
| NCT06392386 | A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With… | Generalized Myasthenia Gravis | Recruiting |
| NCT07194850 | A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age… | Immune Thrombocytopenia (ITP) | Recruiting |
| NCT05374590 | Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod… | Generalized Myasthenia Gravis | Enrolling by Invitation |
| NCT07638566 | A Study to Assess the Correct Dose, Safety and Efficacy of Empasiprubart in Adolescent… | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | Not Yet Recruiting |
| Phase 2 | |||
| NCT06655155 | A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic… | Systemic Sclerosis (SSc) | Recruiting |
| NCT07673627 | ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of… | AChR-Ab Seropositive Generalized Myasthenia Gravis | Recruiting |
| NCT07284420 | ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to… | AChR-Ab Seropositive Generalized Myasthenia Gravis | Recruiting |
| NCT07287982 | A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and… | Spinal Muscular Atrophy (SMA) | Recruiting |
| NCT04280718 | A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of… | Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Active, Not Recruiting |
| NCT06284954 | A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis | Dermatomyositis | Active, Not Recruiting |
| NCT05405361 | A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy… | Multifocal Motor Neuropathy (MMN) | Active, Not Recruiting |